INDIA: For many governments around the world, including America, the COVID-19 drug created by Moderna and Pfizer is said to be the best option at fighting the coronavirus. In America, the Biden administration was so adamant about the COVID-19 drug that Joe Biden tried to force it on America’s workforce. That plan, like several others, backfired and led to a mountain of criticism and lawsuits. But among all the incentives, public relations, and marketing videos, one country continuously refuses to accept the drug by Pfizer or Moderna and up till now, the reason was completely unknown.
Although the COVID-19 drug is pushed and promoted in America, in India, the drug companies were turned away by the government due to their outlandish demands. In the video, which is featured below, Indian Health Minister Mansukh Mandaviya was promoting the book launch of “A Nation to Protect” when he revealed the lack of accountability as the reason Pfizer and Moderna were denied.
Wanting the government to sign an indemnity clause, Pfizer and Moderna would have been untouchable against lawsuits if their supposed miracle drug killed or harmed any person. The health minister noted that it wasn’t wise for the people to accept their demands. But while Pfizer and Moderna were turned away, the country moved forward with their own COVID-19 drugs like Covaxin and Covishield.
The government also supported single-dose shots like Russia’s Sputnik and the one made by Johnson & Johnson.
Having revealed the reason behind the decision, Dr. Suneel Dehand discussed the news revealed by the Health Minister and the effects it had on India.
Take a look.
By
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post